These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15455708)

  • 1. Clinical evaluation and patterns of chemotherapy-induced peripheral neuropathy.
    Visovsky C; Daly BJ
    J Am Acad Nurse Pract; 2004 Aug; 16(8):353-9. PubMed ID: 15455708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral nerve function and symptom distress during biotherapy for malignant melanoma.
    Visovsky CG
    Can Oncol Nurs J; 2005; 15(3):161-74. PubMed ID: 16261812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy-Induced Peripheral Neuropathy in Long-term Survivors of Childhood Cancer: Clinical, Neurophysiological, Functional, and Patient-Reported Outcomes.
    Kandula T; Farrar MA; Cohn RJ; Mizrahi D; Carey K; Johnston K; Kiernan MC; Krishnan AV; Park SB
    JAMA Neurol; 2018 Aug; 75(8):980-988. PubMed ID: 29799906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
    Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
    JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
    Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
    J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurological monitoring of neurotoxicity induced by paclitaxel/cisplatin chemotherapy.
    Berger T; Malayeri R; Doppelbauer A; Krajnik G; Huber H; Auff E; Pirker R
    Eur J Cancer; 1997 Aug; 33(9):1393-9. PubMed ID: 9337680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients treated with antitumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.
    De Santis S; Pace A; Bove L; Cognetti F; Properzi F; Fiore M; Triaca V; Savarese A; Simone MD; Jandolo B; Manzione L; Aloe L
    Clin Cancer Res; 2000 Jan; 6(1):90-5. PubMed ID: 10656436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric evaluation of two scales assessing functional status and peripheral neuropathy associated with chemotherapy for ovarian cancer: a gynecologic oncology group study.
    Almadrones L; McGuire DB; Walczak JR; Florio CM; Tian C
    Oncol Nurs Forum; 2004 May; 31(3):615-23. PubMed ID: 15146227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP.
    Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W
    BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychometric properties of the Turkish version of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool (CIPNAT).
    Kutlutürkan S; Öztürk ES; Arıkan F; Kahraman BB; Özcan K; Uçar MA
    Eur J Oncol Nurs; 2017 Dec; 31():84-89. PubMed ID: 29173832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Paclitaxel pharmacokinetics with the development of peripheral neuropathy in patients with advanced cancer.
    Mielke S; Sparreboom A; Steinberg SM; Gelderblom H; Unger C; Behringer D; Mross K
    Clin Cancer Res; 2005 Jul; 11(13):4843-50. PubMed ID: 16000582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimodal quantitative examination of nerve function in colorectal cancer patients prior to chemotherapy.
    Kandula T; Farrar MA; Krishnan AV; Murray J; Timmins HC; Goldstein D; Lin CS; Kiernan MC; Park SB
    Muscle Nerve; 2018 Apr; 57(4):615-621. PubMed ID: 28881477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral neuropathy in patients with gynecologic cancer receiving chemotherapy: patient reports and provider assessments.
    Kiser DW; Greer TB; Wilmoth MC; Dmochowski J; Naumann RW
    Oncol Nurs Forum; 2010 Nov; 37(6):758-64. PubMed ID: 21059587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral sensory neuropathy and cisplatin chemotherapy.
    Roelofs RI; Hrushesky W; Rogin J; Rosenberg L
    Neurology; 1984 Jul; 34(7):934-8. PubMed ID: 6330613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral neuropathy due to biweekly paclitaxel, epirubicin and cisplatin in patients with advanced ovarian cancer.
    Postma TJ; Hoekman K; van Riel JM; Heimans JJ; Vermorken JB
    J Neurooncol; 1999; 45(3):241-6. PubMed ID: 10845395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
    Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
    Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN).
    Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L
    Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
    Amara S
    Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy-Induced Peripheral Neuropathy.
    Tzatha E; DeAngelis LM
    Oncology (Williston Park); 2016 Mar; 30(3):240-4. PubMed ID: 26984218
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.